Catalina Capital Group LLC Buys 46 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Catalina Capital Group LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 2,714 shares of the medical equipment provider’s stock after acquiring an additional 46 shares during the period. Catalina Capital Group LLC’s holdings in Intuitive Surgical were worth $1,417,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Czech National Bank boosted its stake in shares of Intuitive Surgical by 6.9% in the 3rd quarter. Czech National Bank now owns 72,257 shares of the medical equipment provider’s stock valued at $35,498,000 after purchasing an additional 4,665 shares in the last quarter. HBW Advisory Services LLC purchased a new stake in Intuitive Surgical during the third quarter valued at about $235,000. GAMMA Investing LLC grew its stake in shares of Intuitive Surgical by 31.2% during the third quarter. GAMMA Investing LLC now owns 5,090 shares of the medical equipment provider’s stock valued at $2,501,000 after buying an additional 1,211 shares during the last quarter. Consilio Wealth Advisors LLC purchased a new position in shares of Intuitive Surgical in the third quarter worth about $218,000. Finally, Miracle Mile Advisors LLC lifted its stake in shares of Intuitive Surgical by 7.7% in the 3rd quarter. Miracle Mile Advisors LLC now owns 1,805 shares of the medical equipment provider’s stock valued at $887,000 after acquiring an additional 129 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 28,843 shares of company stock worth $15,357,560. 0.80% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities analysts recently issued reports on ISRG shares. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Robert W. Baird upped their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Mizuho raised their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $571.88 on Monday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a market cap of $203.69 billion, a price-to-earnings ratio of 89.22, a PEG ratio of 5.51 and a beta of 1.39. The company has a 50-day moving average of $550.40 and a 200 day moving average of $509.43.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.